✦ LIBER ✦

PCN28 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB-CHOP VS. CHOP ON NON-HODGKIN LYMPHOMA PATIENTS IN THE MEXICAN CONTEXT

✍ Scribed by D Cortina; R Rivera-Hurtado; C Aleman; I Egoavil; L Gonzalez-Michaca

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CN2 COST-EFFECTIVENESS ANALYSIS OF RITUX

✍ P Berto; A Morsanutto; S Lopatriello 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN12 COST-EFFECTIVENESS ANALYSIS OF G-C

✍ GH Lyman; LE Cosier 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PSY14 COST-EFFECTIVENESS (CE) EVALUATION

✍ E Cervera-Ceballos; A Meneses; J Vargas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Cost-Effectiveness Analysis of the Addit

✍ Felicetto Ferrara, Dr Roberto Ravasio 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

PCN69 Cost-Effectiveness Analysis of Mai

✍ F. Demousis; A. Athanasiadis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

CNOP (mitoxantrone) chemotherapy is infe

✍ Björkholm Magnus; Andersson Tomas; Ahlbom Anders; Ösby Eva 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB